Diabetes decisions — 2022

The Veteran's claim for a disability rating in excess of 20 percent for diabetes mellitus type II was denied as the evidence did not show that he required regulation of activities.,Service connection for PTSD and left inguinal hernia were both denied due to lack of medical or lay evidence linking these conditions to service.

The Veteran's service connection claims for diabetes mellitus type II and hypertension are granted on a presumptive basis under the 2022 PACT Act. The claim for chest condition with pain is denied.

The Veteran's claims for service connection for a back condition, fibromyalgia, pre-diabetes, swelling of the lower extremities, and swelling of the upper extremities were denied. The Board found no evidence linking these conditions to service or any other relevant factor.,There is no current disability related to the claimed conditions.

The Board has found the eligibility determination for PCAFC benefits to be legally inadequate and remands the case for a new medical determination regarding personal care services, supervision or protection needs, and regular or extensive instruction or supervision.

The Board has granted service connection for diabetes mellitus. The cervical spine disability claim is remanded due to a pre-decisional duty to assist error.

The Board denied the Veteran's claim for service connection for diabetes mellitus type II, finding that it did not have its onset during service and is not otherwise caused by service. The Board also referred to the RO issues of whether the May 2013 rating decision granting service connection for PTSD contains clear and unmistakable error (CUE) and whether severance of service connection for PTSD is appropriate.

The Veteran's service connection for diabetes mellitus type II (DMII) is granted, and the case is remanded for further examination on cerebrovascular accident (CVA) and peripheral neuropathy.

The Veteran's service-connected disabilities, including diabetes mellitus, type II, with bilateral cataracts and right eye retinopathy, peripheral neuropathy of the lower extremities, and hemorrhoids, are being remanded for additional development to determine their current severity.

The Board has remanded the case due to insufficient evidence regarding the Veteran's exposure to environmental toxins during service, and to obtain a medical opinion on whether his ischemic heart disease and diabetes are related to such exposures.

The Board has remanded the case due to incomplete documentation and need for additional medical opinions.

The Board has dismissed the appeal for service connection for an eye disorder to include diabetic retinopathy as the July 2022 rating decision granted the benefits sought on appeal in full. The TDIU claim is remanded.

The Veteran's prostate cancer, coronary artery disease, and diabetes mellitus type II are presumed to have been incurred in service due to herbicide agent exposure. Service connection is granted for these conditions.

The Board denied the Veteran's claim for service connection for diabetes mellitus type II, finding no evidence of in-service exposure to herbicides and insufficient medical opinion linking the condition to service.

The Veteran's death was caused by ischemic heart disease and diabetes mellitus, type II. The PACT Act grants presumptive service connection for these conditions due to exposure in Thailand during the Vietnam Era.

The Veteran's service-connected PTSD, degenerative lumbar spondylosis, rheumatoid arthritis of the bilateral lower extremities (rhabdomyosarcoma is not a condition, but radiculopathy is attributed to it), diabetes mellitus type II, psoriasis, and hypertensive heart disease have rendered him unable to secure or follow substantially gainful employment from February 9, 2016.,The Veteran's service-connected PTSD, degenerative lumbar spondylosis, rheumatoid arthritis of the bilateral lower extremities (rhabdomyosarcoma is not a condition, but radiculopathy is attributed to it), diabetes mellitus type II, psoriasis, and hypertensive heart disease have rendered him unable to secure or follow substantially gainful employment prior to February 9, 2016.

The Veteran's claim for an initial compensable rating for bilateral hearing loss prior to February 19, 2021, was denied.,The Veteran's claim for a higher rating for bilateral hearing loss from February 19, 2021, was also denied.

The Veteran's claims for increased ratings for diabetic peripheral neuropathy and carpal tunnel syndrome were denied. The Board found that the evidence did not meet the criteria for a higher rating from December 3, 2018 to April 16, 2020.

The Veteran's death was caused by malignant neoplasm of the esophagus, with diabetes significantly contributing to his death. The Board granted service connection for cause of death due to exposure to herbicide agents in Korea and found that the Veteran's type II diabetes is presumptively associated with this exposure. As a result, the claim for nonservice-connected VA survivor's pension benefits was dismissed as moot.

The Veteran's service-connected diabetes mellitus type II and residuals of prostate cancer are granted as presumptively related to his service. The Veteran's pseudofolliculitis barbae (claimed as skin rash on face) is denied, but he is assigned a non-compensable rating.

The Board has denied the Veteran's claims for service connection for diabetes, bilateral lower extremity neuropathy, hypertension, respiratory disability, psychiatric disability, back disability, bilateral hand disability, bilateral elbow disability, and bilateral shoulder disability. The evidence does not show current disabilities for any of these conditions.